COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

June 03, 2019 00:20:43
Episode Cover

Early Post-Cardiac Arrest Catheterization - The COACT Trial

A critical component to post-arrest care for the patient with ROSC following out-of-hospital cardiac arrest is early coronary angiography. Current guidelines recommend immediate cardiac...

Listen

Episode 0

July 08, 2022 00:22:56
Episode Cover

Restrictive Fluid Resuscitation in Sepsis? The CLASSIC Trial

IVF administration is central to the management of patients with sepsis.  Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of...

Listen

Episode 0

February 21, 2022 00:24:01
Episode Cover

Ketamine or Etomidate for RSI?

Etomidate and ketamine are frequently used for RSI in critically ill patients.  Recent articles have raised concern about an increased incidence of post-intubation hypotension...

Listen